Bottom Fishing
- Thread starter themickey
- Start date
U.S. CDC reports 'breakthrough' in vaping lung injury probe as cases top 2,000
Julie Steenhuysen
3 Min Read
CHICAGO, Nov 8 (Reuters)
Tests of lung samples taken from 29 patients with vaping-related lung injuries suggest all contained Vitamin E acetate, a discovery U.S. officials described as a “breakthrough” in the investigation of the nationwide outbreak that topped 2,000 cases this week.
FILE PHOTO: A man uses a vape device in this illustration picture, September 19, 2019. REUTERS/Adnan Abidi/Illustration
The discovery of Vitamin E acetate in lung samples offers the first direct evidence of a link with the substance and vaping-related lung injuries. The substance has also been identified in tests by U.S. and state officials of product samples collected from patients with the vaping injury.
In a telephone briefing on Friday, Dr. Anne Schuchet, principal deputy director of the U.S. Centers for Disease Control and Prevention (CDC), called Vitamin E acetate “a very strong culprit of concern” and referred to the discovery as “a breakthrough” in the investigation.
She cautioned that more work is needed to definitively declare it a cause, and said studies may identify other potential causes of the injuries as well.
Vitamin E acetate is believed to be used as a cutting agent in illicit products containing THC - the component of marijuana that gets people high.
Although the substance was detected in all 29 of the lung samples, which came from patients in several different states, more testing is needed to establish a causal link between exposure and injury, Schuchet said, adding that “many substances are still under investigation.”
On Thursday, the CDC reported there have been 2,051 confirmed and probable U.S. lung injury cases associated with use of e-cigarette, or vaping, products in 49 states, the District of Columbia and the U.S. Virgin Islands, as well as 39 deaths.
Nearly 85 percent of lung injury patients in the nationwide outbreak have reported using products containing THC.
In the CDC analysis, THC was detected in 23 of 28 patient samples of lung cells, including from three patients who said they did not use THC products. Nicotine was detected in 16 of 26 patient samples.
The results were published on Friday in the CDC’s Morbidity and Mortality Weekly Report.
In a separate report in the same journal, the Illinois Department of Public Health found that compared to vapers who did not get sick, those who had a lung injury were significantly more likely to use THC-containing vaping products exclusively or frequently, and were nine times more likely to have purchased products from illicit sources, such as from on-line or off the street.
The vaping injury patients also had a higher rate of using “Dank Vapes,” a class of largely counterfeit THC-containing products, according to the study.
Together, the findings reinforce public health officials’ recommendation that people avoid using e-cigarettes that contain THC or any products that come from illicit sources.
Well maybe now is time to get back in. It may pause at $12.00, but that's a logical entry point, watch how price and volume reacts there.I tried bottom fished GE: At $50, $40, $30, $20, $10 and capitulated, exit all at $6.50.
Did you notice 2019 was very similar to 2015? I thought in 2015 $25 was a logical place. Made a few $ then gave everything back and then some.
Comparisons to a previous event are coincidental, 2015 or any far back date had different circumstances.
Just concentrate on the now, what is stock doing 'now'.
And back then $25 was prolly very logical, but at $30 circumstances changed, the $28 to $32 range then was quite volatile.
If you were to observe price action at $12 when it gets there, it will be (a) a round number, (b) 12 month high.
It may stall at $12 due to being a tad stretched (50% price increase in 3-4 months) but watch how it behaves, will it punch though fast or fall back.
I'd be tempted to buy now actually and place a stop at $9.90, either that or hope it falls back to $10 area and try and get in there. GE is not one I follow so not aware of market news going on atm.
Bottom fishing carries less risk imo, however I do like seeing price clear above previous month high first.
Bottom fishing is akin to going to a casino. Unless you have enough money to turn a nano cap company into a micro cap lett hedge funds do the work. Play the indexes there are enough to keep anyone busy.
Akuma
Listed on ASX, MLX, Metals X is a producer of Tin, Copper, Nickel & Cobalt in Australia.
Bought a position today on market open. $0.18
The woes of the Co. are it appears a slack bunch of directors need to be shown the door quick smart.
As well, their flagship mine 'Nifty' is burning through cash due to a host of mechanical issues.
Apparently also a Chinese Co. APAC Resources is rumoured to be attempting a takeover by stealth.
MLX is another one of those Co's you see regularly who are always full of excuses (Ass covering) on their continual underperformance, read it time & time again, every reporting date, another fvvkn lame excuse, then - "oh but can you approve our bonus". FFS!
Well I'm taking a punt on this sick mother, let's see how this pans out.
My algo says "Buy!". Forget about fundamentals logic, swimming against the tide here.
Regarding my previous bottom fishing stocks on this thread's performance Friday's close:
EVO, Evolve Education, +33%, remaining optimistic this has yet plenty more upside imo.
SDA, -24% Speedcast, This one is in doldrums, stuck in mud. May be some months for recovery, prolly around the next March/April reporting date.
AVL, Aust Vanadium, -20% Showing no life. Bought using an old algo rule which no longer applies, will keep until stopped out as it may run the xmas rally. (However up 10% this morning)
ACW, Actinol Medical +42%, Making money
KAR, Karoon Gas, -8% remaining optimistic
BOT, -14% Botanix Pharma, Tracking sideways from after its big plunge (traders still numb with shock - LOL).
MLX, Metals X, just entered the position.
(% profit/loss includes buy & sell brokerage).
Will hold these until they fall below a new stoploss I created which I am very comfortable with, so that's on trial here too.
Bought a position today on market open. $0.18
The woes of the Co. are it appears a slack bunch of directors need to be shown the door quick smart.
As well, their flagship mine 'Nifty' is burning through cash due to a host of mechanical issues.
Apparently also a Chinese Co. APAC Resources is rumoured to be attempting a takeover by stealth.
MLX is another one of those Co's you see regularly who are always full of excuses (Ass covering) on their continual underperformance, read it time & time again, every reporting date, another fvvkn lame excuse, then - "oh but can you approve our bonus". FFS!
Well I'm taking a punt on this sick mother, let's see how this pans out.
My algo says "Buy!". Forget about fundamentals logic, swimming against the tide here.
Regarding my previous bottom fishing stocks on this thread's performance Friday's close:
EVO, Evolve Education, +33%, remaining optimistic this has yet plenty more upside imo.
SDA, -24% Speedcast, This one is in doldrums, stuck in mud. May be some months for recovery, prolly around the next March/April reporting date.
AVL, Aust Vanadium, -20% Showing no life. Bought using an old algo rule which no longer applies, will keep until stopped out as it may run the xmas rally. (However up 10% this morning)
ACW, Actinol Medical +42%, Making money
KAR, Karoon Gas, -8% remaining optimistic
BOT, -14% Botanix Pharma, Tracking sideways from after its big plunge (traders still numb with shock - LOL).
MLX, Metals X, just entered the position.
(% profit/loss includes buy & sell brokerage).
Will hold these until they fall below a new stoploss I created which I am very comfortable with, so that's on trial here too.